Protective role of metallothionein in chemical and radiation carcinogenesis

Current Pharmaceutical Biotechnology

Volumn 14, Issue 4, 2013, Pages 394-399

  Fujiwara, Yasuyuki ^a   Satoh, Masahiko ^a  

^a AICHI GAKUIN UNIVERSITY   (Japan)

Author keywords

Carcinogen; Carcinogenesis; Knockout mice; Metallothionein; Mutagenesis; Radiation

Indexed keywords

METALLOTHIONEIN; METALLOTHIONEIN I; METALLOTHIONEIN II;

CANCER CHEMOTHERAPY; CHROMOSOME ABERRATION; DNA STRAND BREAKAGE; GENE EXPRESSION; GENOTOXICITY; INCIDENCE; METAL BINDING; NONHUMAN; OXIDATIVE STRESS; RADIATION CARCINOGENESIS; REVIEW; X IRRADIATION; X RAY;

ANIMALS; CARCINOGENESIS; HUMANS; METALLOTHIONEIN; METALS, HEAVY; OXIDATIVE STRESS; POISONING;

MUS;

EID: 84878790641     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/1389201011314040002     Document Type: Review

References (76)

1. Kägi, J.H.R., Kojima, Y. Metallothionein II. Experimenta, 1987, 52 (suppl.), 1-755.
2. Andrews, G.K. Regulation of metallothionein gene expression. Prog. Food Nutr. Sci., 1990, 14, 193-258.
3. Miles, A.T., Hawksworth, G.M., Beattie, J.H., Rodilla, V. Induction, regulation, degradation, and biological significance of mammalian metallothioneins. Crit. Rev. Biochem. Mol. Biol., 2000, 35, 35-70.
4. Palmiter, R.D., Findly, S.D., Whitmore, T.E., Durnam, D.M. MT-III, a brain-specific member of the metallothionein gene family. Proc. Natl. Acad. USA, 1992, 89, 6333-6337.
5. Quaife, C.J., Findley, S.D., Erickson, J.C., Froelick, G.J., Kelly, E.J., Zambrowicz, B.P., Palmiter, R.D. Induction of a new metal-lothionein isoform (MT-IV) occurs during differentiation of stratified squamous epithelia. Biochemistry, 1994, 33, 7250-7259.
6. Cousins, R.J. Absorption, transport, and hepatic metabolism of copper and zinc: special reference to metallothionein and ceru-loplasmin. Physiol. Rev., 1985, 65, 238-309.
7. Shaikh, Z.A. Metallothionein as a storage protein for cadmium: its toxicological implications. Dev. Toxicol. Environ. Sci., 1982, 9, 69-76.
8. Satoh, M., Naganuma, A., Imura, N. Involvement of cardiac metal-lothionein in prevention of adriamycin induced lipid peroxidation in the heart. Toxicology, 1988, 53, 231-237.
9. Sato, M., Bremner, I. Oxygen free radicals and metallothionein. Free Radic. Biol. Med., 1993, 14, 325-337.
10. Cai, L., Satoh, M., Tohyama, C., Cherian, M.G. Metallothionein in radiation exposure its induction and protective role. Toxicology, 1999, 132, 85-98.
11. Cai, L., Klein, J.B., Kang, Y.J. Metallothionein inhibits peroxyni- trite-induced DNA and lipoprotein damage. J. Biol. Chem., 2000, 275, 38957-38960.
12. Poswillo, D.E., Cohen, B. Inhibition of carcinogenesis by dietary zinc. Nature, 1971, 231, 447-448.
13. Duncan, J.R., Dreosti, I.E. Zinc intake, neoplastic DNA synthesis, and chemical carcinogenesis in rats and mice. J. Nati. Cancer Inst., 1975, 55, 195-196.
14. Waalkes, M.P., Diwan, B.A., Weghorst, C.M., Bare, R.M., Ward, J.M., Rice, J.M. Anticarcinogenic effects of cadmium in B6C3F1 mouse liver and lung. Toxicol. Appl. Pharmacol., 1991, 110, 327-335.
15. Gunn, S.A., Gould, T.C., Anderson, W.A. Cadmium-induced interstitial cell tumors in rat and mice and their prevention by zinc. J. Natl. Cancer Inst., 1963, 31, 745-759.
16. Gunn, S.A., Gould, T.C., Anderson, W.A. Effect of zinc on car-cinogenesis by cadmium. Proc. Soc. Exp. Biol. Med., 1964, 115, 653-657.
17. Waalkes, M.P., Rehm, S., Riggs, C.W., Bare, R.M., Devor, D.E., Poirier, L.A., Wenk, M.L., Henneman, J.R. Cadmium carcinogene-sis in male Wistar [Crl:(WI)BR] rats: dose-response analysis of effects of zinc on tumor induction in the prostate, in the testes, and at the injection site. Cancer Res., 1989. 49, 4282-4288.
18. Satoh, M., Kondo, Y., Mita, M., Naganuma, A., Imura, N. Prevention of carcinogenicity of anti cancer drugs by metallothionein induction. Cancer Res., 1993, 53, 4767-4768.
19. Kagimoto, O., Naganuma, A., Imura, N., Toge, T., Niwa, O., Yo-koro, K. Effect of the administration of bismuth nitrate on radiogenic thymoma induction in mice. J. Radiat. Res. (Tokyo), 1991, 32, 417-428.
20. Palmiter, R.D., Sandgren, E.P., Koeller, D.M., Brinster, R.L. Distal regulatory elements from the mouse metallothionein locus stimulate gene expression in transgenic mice. Mol. Cell. Biol., 1993, 13, 5266-5275.
21. Michalska, A.E., Choo, K.H. Targeting and germ-line transmission of a null mutation at the metallothionein I and II loci in mouse. Proc. Natl. Acad. Sci. USA, 1993, 90, 8088-8092.
22. Masters, B.A., Kelly, E.J., Quaife, C.J., Brinster, R.L., Palmiter, R.D. Targeted disruption of metallothionein I and II genes increases sensitivity to cadmium. Proc. Natl. Acad. Sci. USA, 1994, 91, 584-588.
23. Liu, J., Liu, Y., Habeebu, S.S., Klaassen, C.D. Susceptibility of MT-null mice to chronic CdCl2-induced nephrotoxicity indicates that renal injury is not mediated by the CdMT complex. Toxicol. Sci., 1998, 46, 197-203.
24. Liu, Y., Liu, J., Habeebu, S.M., Waalkes, M.P., Klaassen, C.D. Metallothionein-I/II null mice are sensitive to chronic oral cadmium-induced nephrotoxicity. Toxicol. Sci., 2000, 57, 167-176.
25. Liu, J., Liu, Y., Michalska, A.E., Choo, K.H., Klaassen, C.D. Met-allothionein plays less of a protective role in cadmium-metallothionein-induced nephrotoxicity than in cadmium chloride-induced hepatotoxicity. J. Pharmacol. Exp. Ther., 1996, 276, 1216-1223.
26. Habeebu, S.S., Liu, J., Liu, Y., Klaassen, C.D. Metallothionein-null mice are more sensitive than wild-type mice to liver injury induced by repeated exposure to cadmium. Toxicol. Sci., 2000, 55, 223-232.
27. Habeebu, S.S., Liu, J., Liu, Y., Klaassen, C.D. Metallothionein-null mice are more susceptible than wild-type mice to chronic CdCl2-induced bone injury. Toxicol. Sci., 2000, 56, 211-219.
28. Liu, J., Liu, Y., Habeebu, S.S., Klaassen, C.D. Metallothionein-null mice are highly susceptible to the hematotoxic and immunotoxic effects of chronic CdCl2 exposure. Toxicol. Appl. Pharmacol., 1999, 159, 98-108.
29. Satoh, M, Nishimura, N., Kanayama, Y., Naganuma, A., Suzuki, T., Tohyama, C. Enhanced renal toxicity by inorganic mercury in metallothionein-null mice. J. Pharmacol. Exp. Ther., 1997, 283, 1529-1533.
30. Yoshida, M., Satoh, M., Shimada, A., Yasutake, A., Sumi, Y., Tohyama, C. Pulmonary toxicity caused by acute exposure to mercury vapor is enhanced in metallothionein-null mice. Life Sci., 1999, 64, 1861-1867.
31. Kelly, E.J., Quaife, C.J., Froelick, G.J., Palmiter, R.D. Metal-lothionein I and II protect against zinc deficiency and zinc toxicity in mice. J. Nutr., 1996, 126, 1782-1790.
32. Liu, J., Liu, Y., Goyer, R.A., Achanzar, W., Waalkes, M.P. Metal-lothionein-I/II null mice are more sensitive than wild-type mice to the hepatotoxic and nephrotoxic effects of chronic oral or injected inorganic arsenicals. Toxicol. Sci., 2000, 55, 460-467.
33. Sato, M., Apostolova, M.D., Hamaya, M., Yamaki, J., Choo, K.H.A., Michalska, A.E., Kodama, N., Tohyama, C. Susceptibility of metallothionein-null mice to paraquat. Environ. Toxicol. Pharmacol., 1996, 1, 221-225.
34. Zhang, B., Satoh, M., Tohyama, C. Protective role of metal-lothionein in acetaminophen-caused liver toxicity via oxidative stress. J. Health Sci., 1999, 45, 15-19.
35. Liu, J., Liu, Y., Hartley, D., Klaassen, C.D., Shehin-Johnson, S.E., Lucas, A., Cohen, S.D. Metallothionein-I/II knockout mice are sensitive to acetaminophen-induced hepatotoxicity. J. Pharmacol. Exp. Ther., 1999, 289, 580-586.
36. Rofe, A.M., Barry, E.F., Shelton, T.L., Philcox, J.C., Coyle, P. Paracetamol hepatotoxicity in metallothionein-null mice. Toxicology, 1998, 125, 131-140.
37. Takano, H., Satoh, M., Shimada, A., Sagai, M., Yoshikawa, T., Tohyama, C. Cytoprotection by metallothionein against gastroduo-denal mucosal injury caused by ethanol in mice. Lab. Invest., 2000, 80, 371-377.
38. Shibuya, K., Suzuki, J.S., Kito, H., Naganuma, A., Tohyama, C., Satoh, M. Protective role of metallothionein in bone marrow injury caused by X-irradiation. J. Toxicol. Sci., 2008, 33, 479-484.
39. Hanada, K., Sawamura, D., Hashimoto, I., Kida, K., Naganuma, A. Epidermal proliferation of the skin in metallothionein-null mice. J. Invest. Dermatol., 1998, 110, 259-262.
40. Hanada, K., Sawamura, D., Tamai, K., Baba, T., Hashimoto, I., Muramatsu, T., Miura, N., Naganuma, A. Novel function of metal-lothionein in photoprotection: metallothionein-null mouse exhibits reduced tolerance against ultraviolet B injury in the skin. J. Invest. Dermatol., 1998, 111, 582-585.
41. Liu, Y., Hartley, D.P., Liu, J. Protection against carbon tetrachlo-ride hepatotoxicity by oleanolic acid is not mediated through metal-lothionein. Toxicol. Lett., 1998, 95, 77-85.
42. Itoh, N., Kimura, T., Nakanishi, H., Muto, N., Kobayashi, M., Kitagawa, I., Tanaka, K. Metallothionein-independent hepatoprotection by zinc and sakuraso-saponin. Toxicol. Lett., 1997, 93, 135-140.
43. Satoh, M., Aoki, Y., Tohyama, C. Protective role of metal-lothionein in renal toxicity of cisplatinum. Cancer Chemother. Pharmacol., 1997, 40, 358-362.
44. Liu, J., Liu, Y., Habeebu, S.S., Klaassen, C.D. Metallothionein (MT)-null mice are sensitive to cisplatin-induced hepatotoxicity. Toxicol. Appl. Pharmacol., 1998, 149, 24-31.
45. Kimura, T., Fujita, I., Itoh, N., Muto, N., Nakanishi, T., Takahashi, K., Azuma, J., Tanaka, K. Metallothionein acts as a cytoprotectant against doxorubicin toxicity. J. Pharmacol. Exp. Ther., 2000, 292, 299-302.
46. Apostolova, M.D., Choo, K.H., Michalska, A.E., Tohyama, C. Analysis of the possible protective role of metallothionein in strep-tozotocin-induced diabetes using metallothionein-null mice. J. Trace Elem. Med. Biol., 1997, 11, 1-7.
47. Durnam, D.M., Palmiter, R.D. Induction of metallothionein-I mRNA in cultured cells by heavy metals and iodoacetate: evidence for gratuitous inducers. Mol, Cell, Biol., 1984, 4, 484-491.
48. Satoh, M., Cherian, M.G., Imura, N., Shimizu, H. Modulation of resistance to anticancer drugs by inhibition of metallothionein synthesis. Cancer Res., 1994, 54, 5255-5257.
49. Conrad, C.C., Walter, C.A., Richardson, A., Hanes, M.A., Grabowski, D.T. Cadmium toxicity and distribution in metal-lothionein-I and -II deficient transgenic mice. J. Toxicol. Environ. Health, 1997, 52, 527-543.
50. Matsubara, J. Metallothionein induction: a measure of radioprotective action. Health Phys., 1988, 55, 433-436.
51. Satoh, M., Miura, N., Naganuma, A., Matsuzaki, N., Kawamura, E., Imura, N. Prevention of adverse effects of gamma-ray irradiation after metallothionein induction by bismuth subnitrate in mice. Eur. J. Cancer. Clin. Oncol., 1989, 25, 1727-1731.
52. Miura, N., Satoh, M., Imura, N., Naganuma, A. Protective effect of bismuth nitrate against injury to the bone marrow by gamma-irradiation in mice: possible involvement of induction of metallothionein synthesis. J. Pharmacol. Exp. Ther., 1998, 286, 1427-1430.
53. Nakagawa, I., Nishi, E., Naganuma, A., Imura, N. Effect of preinduction of metallothionein synthesis on clastogenicity of anticancer drugs in mice. Mutat. Res., 1995, 348, 37-43.
54. Itoh, S., Shimada, H. Micronucleus induction by chromium and selenium, and suppression by metallothionein inducer. Mutat. Res., 1996, 367, 233-236.
55. Takaishi, M., Suzuki, J.S., Satoh, M., Nagase, H. Preventive effect of preinduction of metallothionein on mutagenicity caused by benzo[a]pyrene. J. Health Sci., 2010, 56, 65-71.
56. Zhang, B., Satoh, M., Nishimura, N., Suzuki, J.S., Sone, H., Aoki, Y., Toyama, C. Metallothionein deficiency promotes mouse skin carcinogenesis induced by 7,12-dimethylbenz[a]anthracene. Cancer Res., 1998, 58, 4044-4046.
57. Suzuki, J.S., Nishimura, N., Zhang, B., Nakatsuru, Y., Kobayashi, S., Satoh, M., Toyama, C. Metallothionein deficiency enhances skin carcinogenesis induced by 7,12-dimethylbenz[a]anthracene and 12-O-tetradecanoylphorbol-13-acetate in metallothionein-null mice. Carcinogenesis, 2003, 24, 1123-1132.
58. Satoh, M., Murata, M., Nishimura, N., Suzuki, J.S., Toyama, C. Enhanced chemical carcinogenesis in the stomach of metallothionein-null mice. Biomed. Res. Trace Elements, 2001, 12, 343-344.
59. Shibuya, K., Nishimura, N., Suzuki, J.S., Thoyama, C., Naganuma, A., Satoh, M. Role of metallothionein as a protective factor against radiation carcinogenesis. J. Toxicol. Sci., 2008, 33, 651-655.
60. Takaishi, M., Shimada, A., Suzuki, J.S., Satoh, M., Nagase, H. Involvement of metallothionein (MT) as a biological protective factor against carcinogenesis induced by benzo[a]pyrene (B[a]P). J. Toxicol. Sci., 2010, 35, 225-230.
61. Takaishi, M., Sawada, M., Shimada, A., Suzuki, J.S., Satoh, M., Nagase, H. Protective role of metallothionein in benzo[a]pyrene-induced DNA damage. J. Toxicol. Sci., 2009, 34, 449-458.
62. Jia, G., Sone, H., Nishimura, N., Satoh, M., Tohyama, C. Metal-lothionein (I/II) suppresses genotoxicity caused by dimethylarsinic acid. Int. J. Oncol., 2004, 25, 325-333.
63. Kondo, Y., Himeno, S., Endo, W., Mita, M., Suzuki, Y., Nemoto, K., Akimoto, M., Lazo, J., Imura, N. Metallothionein modulates the carcinogenicity of N-butyl-N-(4-hydroxybutyl) nitrosamine in mice. Carcinogenesis, 1999, 20, 1625-1627.
64. Waalkes, M.P., Liu, J., Goyer, R.A., Diwan, B.A. Metallothionein-I/II double knockout mice are hypersensitive to lead-induced kidney carcinogenesis: role of inclusion body formation. Cancer Res., 2004, 64, 7766-7772.
65. Waalkes, M.P., Liu, J., Kasprzak, K.S., Diwan, B.A. Hypersuscep-tibility to cisplatin carcinogenicity in metallothionein-I/II double knockout mice: Production of hepatocellular carcinoma at clinically relevant doses. Int. J. Cancer, 2006, 119, 28-32.
66. Zheng, H., Liu, J., Choo, K.H., Michalska, A.E., Klaassen, C.D. Metallothionein-I and -II knock-out mice are sensitive to cadmium-induced liver mRNA expression of c-jun and p53. Toxicol. Appl. Pharmacol., 1996, 136, 229-235.
67. Waalkes, M.P., Liu, J., Kasprzak, K.S., Diwan, B.A. Metal-lothionein-I/II double knockout mice are no more sensitive to the carcinogenic effects of nickel subsulfide than wild-type mice. Int. J. Toxicol., 2005, 24, 215-220.
68. Ng, J.C., Seawright, A.A., Chiswell, B., Moore, M.R. Tumors in C57BL/6J and metallothionein knock-out transgenic mice induced by chronic arsenic exposure over two years. Toxicol. Lett., 1998, 95, pp. 183-183(1).
69. Conney, A.H., Chang, R.L., Jerina, D.M., Wei, S.J. Studies on the metabolism of benzo[a]pyrene and dose-dependent differences in the mutagenic profile of its ultimate carcinogenic metabolite. Drug Metab. Rev., 1994, 26, 125-163.
70. Melikian, A.A., Bagheri, K., Hoffmann, D. Oxidation and DNA binding of (+)-7,8- dihydroxy-7,8-dihydrobenzo(a)pyrene in mouse epidermis in vivo and effects of coadministration of catechol. Cancer Res., 1990, 50, 1795-1799.
71. Wei, D., Maher, V.M., McCormick, J.J. Effect of nuclear environment on the distribution of benzo[a]pyrene diol epoxide-induced adducts in the HPRT gene of human fibroblasts. Carcinogenesis, 1996, 17, 2695-2701.
72. Mehrotra, K., Constantin, D., Wallin, A., Moldéus, P., Jernström, B. Nitrite-stimulated DNA-binding of carcinogenic diol epoxides from benzo[a]pyrene-7,8-dihydrodiol in human polymorphonuclear leukocytes. Cancer Lett., 1994, 78, 49-56.
73. Chiapperino, D., Cai, M., Sayer, J.M., Yagi, H., Kroth, H., Masu-tani, C., Hanaoka, F., Jerina, D.M., Cheh, A.M. Error-prone translation synthesis by human DNA polymerase eta on DNA-containing deoxyadenosine adducts of 7,8-dihydroxy-9,10-epoxy-7,8,9,10- tetrahydrobenzo[a]pyrene. J. Biol. Chem., 2005, 280, 39684-39692.
74. Lorentzen, R.J., Ts'o, P.O. Benzo[a]yrenedione/benzo[a]pyrenediol oxidation-reduction couples and the generation of reactive reduced molecular oxygen. Biochemistry, 1977, 16, 1467-1473.
75. Yoshida, M., Ohta, H., Yamauchi, Y., Seki, Y., Sagi, M., Yamazaki, K., Sumi, Y. Age-dependent changes in metallothionein levels in liver and kidney of the Japanese. Biol. Trace Elem. Res., 1998, 63, 167-175.
76. Kita, K., Miura, N., Yoshida, M., Yamazaki, K., Ohkubo, T., Imai, Y., Naganuma, A. Potential effect on cellular response to cadmium of a single-nucleotide A --> G polymorphism in the promoter of the human gene for metallothionein IIA. Hum. Genet., 2006, 120, 553-560.